Re­lay Ther­a­peu­tics’ stock $RLAY rose about 6% on Wednes­day morn­ing af­ter it re­leased pos­i­tive in­ter­im da­ta for ...

Companies Beam Therapeutics and Prime Medicines presented research on reducing chemotherapy in gene therapy conditioning, ...

Ace­lyrin is of­fi­cial­ly end­ing de­vel­op­ment of an ex­per­i­men­tal med­i­cine it re­ferred to as a “ di­a­mond in the ...

Through a new relationship with Eli Lilly, Ro patients can now get easier access to the drugmaker’s discounted, single-dose ...

Data from a Phase 3 study in second-line breast cancer showed that Eli Lilly’s oral SERD reduced the risk of progression or ...

Angitia Biopharmaceuticals secured $120 million Series C funding led by Bain Capital Life Sciences. The biotech, founded by ...

A new psychedelic-focused startup incubator is debuting, backed by an investor behind some of the most prominent biotechs in ...

Moberg Pharma's Terclara fails Phase 3 trial for fungal nail infection maintenance dosing; Bayer exits partnership and ...

Chroma Medicine and Nvelop Therapeutics announced their merger to form nChroma Bio, resulting from a September dinner between ...

A survey of 77 biotech executives reveals concerns about FDA changes following Donald Trump's reelection. Martin Makary's ...

Ahead of an advisory committee meeting later this week, the FDA revealed that all studies for RSV vaccines in young children ...

Drug developers are making a new generation of treatments for blood cancers that arise from abnormal B cells by taking ...